Shandong Kexing Bioproducts Co,.Ltd (688136.SS)
CNY 20.64
(5.84%)
CNY 20.64
(5.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -87.13 Million | -85.88 Million | 94.01 Million | 105.93 Million | 5.25 Million | 63.43 Million |
| Net Income | -195.48 Million | -92.82 Million | 96.46 Million | 139.13 Million | 159.81 Million | 94.16 Million |
| Depreciation & Amortization | 88.25 Million | 71.04 Million | 49.88 Million | 29.14 Million | 24.23 Million | 20.67 Million |
| Deferred income taxes | -70.31 Million | -47.32 Million | -1.22 Million | 566.34 Thousand | - | - |
| Stock-based compensation | 7.71 Million | - | - | - | - | 37.79 Million |
| Change in working capital | -30.41 Million | -108.06 Million | -15.06 Million | -90.37 Million | -209.37 Million | -118.26 Million |
| Other non-cash items | 49 Million | 43.96 Million | -37.26 Million | 28.03 Million | 30.58 Million | 66.86 Million |
| Investing Cash Flow | -156.24 Million | -381.44 Million | -492.49 Million | -200.55 Million | -53.59 Million | -197.87 Million |
| Investments in PPE | -191.2 Million | -399.16 Million | -371.98 Million | -188.96 Million | -53.57 Million | -40.23 Million |
| Acquisitions | - | 1.77 Million | 64.47 Million | 510.44 Thousand | 1100.00 | 1200.00 |
| Investment purchases | -1.97 Billion | -1.39 Billion | -2.25 Billion | - | - | - |
| Sales/Maturities of investments | 1.99 Billion | 1.39 Billion | 2.06 Billion | - | - | - |
| Other Investing Activities | 15.99 Million | 12.11 Million | 5.82 Million | -12.09 Million | -20 Thousand | -157.63 Million |
| Financing Cash Flow | 16.24 Million | 371.09 Million | 186.93 Million | 1.03 Billion | 152.23 Million | 114.98 Million |
| Debt repayment | -66.6 Million | -573.18 Million | -264.19 Million | -221.08 Million | -84.96 Million | -213.86 Million |
| Dividends payments | -45.41 Million | -19.87 Million | -15.89 Million | -10.86 Million | -7.01 Million | -9.69 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.94 Million | 997.9 Million | 479.51 Million | 1.26 Billion | 244.21 Million | 338.53 Million |
| Accounts receivables | -70.16 Million | -85.91 Million | -66.52 Million | -123.2 Million | -142.08 Million | - |
| Accounts payables | 124.92 Million | 60.42 Million | 111.97 Million | 5.31 Million | 142.08 Million | - |
| Inventory | -14.86 Million | -35.25 Million | -59.27 Million | 26.94 Million | -52.98 Million | 5.29 Million |
| Other working capital | 7.71 Million | -47.32 Million | -1.22 Million | 566.34 Thousand | -156.38 Million | -123.56 Million |
| Cash at beginning of period | 783.97 Million | 874.77 Million | 1.08 Billion | 150.35 Million | 46.23 Million | 65.9 Million |
| Cash at end of period | 559.93 Million | 783.97 Million | 874.77 Million | 1.08 Billion | 150.35 Million | 46.23 Million |
| Capital Expenditure | -191.2 Million | -399.16 Million | -371.98 Million | -188.96 Million | -53.57 Million | -40.23 Million |
| Effect of forex changes on cash | 3.09 Million | 5.43 Million | -2.06 Million | -3.31 Million | 218.65 Thousand | -219.71 Thousand |
| Net cash flow / Change in cash | -224.04 Million | -90.8 Million | -213.61 Million | 938.02 Million | 104.11 Million | -19.66 Million |
| Free Cash Flow | -278.33 Million | -485.05 Million | -277.96 Million | -83.03 Million | -48.31 Million | 23.19 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.3 Million | -526.11 Thousand | 12.4 Million | -195.48 Million | -131.44 Million | -6.75 Million |
| Depreciation & Amortization | - | 25.62 Million | 25.62 Million | 88.25 Million | 88.25 Million | -42.72 Million |
| Deferred income taxes | - | - | - | -70.31 Million | - | 66.76 Million |
| Stock-based compensation | - | - | - | 7.71 Million | 7.71 Million | -5.31 Million |
| Change in working capital | - | - | - | -30.41 Million | -77.31 Million | -19.86 Million |
| Other non-cash items | 83.8 Million | 1.1 Million | -18.62 Million | 49 Million | 131.44 Million | 20.53 Million |
| Investing Cash Flow | -113.53 Million | 99.94 Million | -224.08 Million | -156.24 Million | 272.75 Million | -148.9 Million |
| Investments in PPE | -16.33 Million | -13.15 Million | -37.75 Million | -191.2 Million | -17.42 Million | -42.99 Million |
| Acquisitions | 27.91 Thousand | 3310.00 | - | - | -4.9 Million | - |
| Investment purchases | -629 Million | -437 Million | -579 Million | -1.97 Billion | -438.5 Million | -575 Million |
| Sales/Maturities of investments | 542.8 Million | 551 Million | 392.29 Million | 1.99 Billion | 720.63 Million | 477.64 Million |
| Other Investing Activities | -11.01 Million | -899.51 Thousand | 375.71 Thousand | 15.99 Million | 8.03 Million | -8.54 Million |
| Financing Cash Flow | -107.31 Million | 16.24 Million | 16.58 Million | 16.24 Million | -29.24 Million | -75.14 Million |
| Debt repayment | -93.39 Million | -42.89 Million | -49.92 Million | -66.6 Million | -14.56 Million | -115.69 Million |
| Dividends payments | -11.49 Million | -11.04 Million | -10.95 Million | -45.41 Million | -10.3 Million | -11.14 Million |
| Common Stock Repurchased | - | - | - | - | - | 7.81 Million |
| Common Stock Issuance | - | - | - | - | - | -7.81 Million |
| Other Financing Activities | -2.42 Million | 11.33 Million | -22.38 Million | -4.94 Million | -4.36 Million | 51.68 Million |
| Accounts receivables | - | - | - | -70.16 Million | -70.16 Million | 15.26 Million |
| Accounts payables | - | - | - | 124.92 Million | - | 6.7 Million |
| Inventory | - | - | - | -14.86 Million | -14.86 Million | -35.12 Million |
| Other working capital | - | - | - | 7.71 Million | 7.71 Million | -6.7 Million |
| Cash at beginning of period | 438.32 Million | 353.78 Million | 559.93 Million | 783.97 Million | 329.21 Million | 540.1 Million |
| Cash at end of period | 304.52 Million | 439.75 Million | 346.87 Million | 559.93 Million | 559.93 Million | 329.21 Million |
| Capital Expenditure | -16.33 Million | -13.15 Million | -37.75 Million | -191.2 Million | -17.42 Million | -42.99 Million |
| Effect of forex changes on cash | -239.34 Thousand | 310.97 Thousand | 660.13 Thousand | 3.09 Million | -151.43 Thousand | 523.08 Thousand |
| Net cash flow / Change in cash | -133.79 Million | 85.96 Million | -213.06 Million | -224.04 Million | 230.71 Million | -210.88 Million |
| Free Cash Flow | 72.77 Million | -38.2 Million | -43.97 Million | -278.33 Million | -30.06 Million | -30.34 Million |
092040
CMXHF
EESE
1618
SHBAJRG
300801